[Peripheral perfusion in CAD patients with various-stage chronic heart failure undergoing coronary artery bypass

O V Kamenskaia1, A S Klinkova1, D V Khabarov2

  • 1Novosibirsk Scientific Research Institute of Circulatory Pathology named after Academician E.N. Meshalkin under the RF Ministry of Public Health, Novosibirsk, Russia.

Insights

Patients with severe chronic heart failure (CHF) show impaired microcirculatory blood flow (MCB) adaptation during orthostatic tests before and after coronary artery bypass grafting (CABG). These findings highlight significant peripheral perfusion deficits in advanced CHF patients undergoing CABG.

Area of Science:

  • Cardiology
  • Vascular Physiology
  • Surgical Outcomes

Background:

  • Coronary artery disease (CAD) with chronic heart failure (CHF) significantly impacts peripheral circulation.
  • Orthostatic testing is crucial for assessing cardiovascular adaptation.
  • Understanding microcirculatory changes is vital for managing patients undergoing coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To evaluate peripheral perfusion and microcirculatory blood flow (MCB) adaptation in patients with CAD and varying functional classes (FC) of CHF.
  • To compare these parameters before and after CABG.
  • To identify predictors of impaired tissue oxygenation and peripheral vascular complications post-CABG.

Main Methods:

  • Utilized laser Doppler flowmetry (LDF) to measure MCB velocity in lower limbs.
  • Employed transcutaneous oximetry to assess partial oxygen pressure (TcPO2).
  • Conducted orthostatic tests on 104 patients with CAD (FC II-IV CHF) pre- and post-CABG.

Main Results:

  • Patients with FC III-IV CHF exhibited significantly lower MCB and impaired reactivity during orthostatic tests compared to FC II patients, both pre- and post-CABG.
  • A paradoxical MCB reaction and lack of MCB response during orthostatic tests were more prevalent in FC III-IV CHF patients.
  • Reduced resting TcPO2 and impaired tissue metabolic reactivity were observed in FC III-IV CHF patients. Low ejection fraction (<42%) predicted lower post-CABG TcPO2, while lack of MCB response predicted lower limb artery disease.

Conclusions:

  • Pronounced impairments in MCB adaptation during orthostatic tests are characteristic of CAD patients with FC III-IV CHF.
  • Decreased microvascular tonicity and inhibited nutritive blood flow, coupled with low metabolic reactivity, characterize these patients.
  • Orthostatic test findings can predict post-CABG outcomes and the risk of peripheral vascular complications.